Tartaglia J - Search Results

1

Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaques.

Hel Z, Venzon D, Poudyal M, Tsai WP, Giuliani L, Woodward R, Chougnet C, Shearer G, Altman JD, Watkins D, Bischofberger N, Abimiku A, Markham P, Tartaglia J, Franchini G. Hel Z, et al. Among authors: tartaglia j. Nat Med. 2000 Oct;6(10):1140-6. doi: 10.1038/80481. Nat Med. 2000. PMID: 11017146

2

Vaccination of macaques with long-standing SIVmac251 infection lowers the viral set point after cessation of antiretroviral therapy.

Tryniszewska E, Nacsa J, Lewis MG, Silvera P, Montefiori D, Venzon D, Hel Z, Parks RW, Moniuszko M, Tartaglia J, Smith KA, Franchini G. Tryniszewska E, et al. Among authors: tartaglia j. J Immunol. 2002 Nov 1;169(9):5347-57. doi: 10.4049/jimmunol.169.9.5347. J Immunol. 2002. PMID: 12391256

3

HIV-1 recombinant poxvirus vaccine induces cross-protection against HIV-2 challenge in rhesus macaques.

Abimiku AG, Franchini G, Tartaglia J, Aldrich K, Myagkikh M, Markham PD, Chong P, Klein M, Kieny MP, Paoletti E, et al. Abimiku AG, et al. Among authors: tartaglia j. Nat Med. 1995 Apr;1(4):321-9. doi: 10.1038/nm0495-321. Nat Med. 1995. PMID: 7585061

4

Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure.

Benson J, Chougnet C, Robert-Guroff M, Montefiori D, Markham P, Shearer G, Gallo RC, Cranage M, Paoletti E, Limbach K, Venzon D, Tartaglia J, Franchini G. Benson J, et al. Among authors: tartaglia j. J Virol. 1998 May;72(5):4170-82. doi: 10.1128/JVI.72.5.4170-4182.1998. J Virol. 1998. PMID: 9557706 Free PMC article.

5

Potentiation of simian immunodeficiency virus (SIV)-specific CD4(+) and CD8(+) T cell responses by a DNA-SIV and NYVAC-SIV prime/boost regimen.

Hel Z, Tsai WP, Thornton A, Nacsa J, Giuliani L, Tryniszewska E, Poudyal M, Venzon D, Wang X, Altman J, Watkins DI, Lu W, von Gegerfelt A, Felber BK, Tartaglia J, Pavlakis GN, Franchini G. Hel Z, et al. Among authors: tartaglia j. J Immunol. 2001 Dec 15;167(12):7180-91. doi: 10.4049/jimmunol.167.12.7180. J Immunol. 2001. PMID: 11739541

6

Design and in vivo immunogenicity of a polyvalent vaccine based on SIVmac regulatory genes.

Hel Z, Tryniszewska E, Tsai WP, Johnson JM, Harrod R, Fullen J, Kalyanaraman VS, Altman JD, McNally J, Karpova T, Felber BK, Tartaglia J, Franchini G. Hel Z, et al. Among authors: tartaglia j. DNA Cell Biol. 2002 Sep;21(9):619-26. doi: 10.1089/104454902760330156. DNA Cell Biol. 2002. PMID: 12396604

7

Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses.

Hel Z, Nacsa J, Tryniszewska E, Tsai WP, Parks RW, Montefiori DC, Felber BK, Tartaglia J, Pavlakis GN, Franchini G. Hel Z, et al. Among authors: tartaglia j. J Immunol. 2002 Nov 1;169(9):4778-87. doi: 10.4049/jimmunol.169.9.4778. J Immunol. 2002. PMID: 12391187

8

A novel chimeric Rev, Tat, and Nef (Retanef) antigen as a component of an SIV/HIV vaccine.

Hel Z, Johnson JM, Tryniszewska E, Tsai WP, Harrod R, Fullen J, Tartaglia J, Franchini G. Hel Z, et al. Among authors: tartaglia j. Vaccine. 2002 Aug 19;20(25-26):3171-86. doi: 10.1016/s0264-410x(02)00258-x. Vaccine. 2002. PMID: 12163269

9

Modeling a safer smallpox vaccination regimen, for human immunodeficiency virus type 1-infected patients, in immunocompromised macaques.

Edghill-Smith Y, Venzon D, Karpova T, McNally J, Nacsa J, Tsai WP, Tryniszewska E, Moniuszko M, Manischewitz J, King LR, Snodgrass SJ, Parrish J, Markham P, Sowers M, Martin D, Lewis MG, Berzofsky JA, Belyakov IM, Moss B, Tartaglia J, Bray M, Hirsch V, Golding H, Franchini G. Edghill-Smith Y, et al. Among authors: tartaglia j. J Infect Dis. 2003 Oct 15;188(8):1181-91. doi: 10.1086/378518. Epub 2003 Oct 10. J Infect Dis. 2003. PMID: 14551889

10

Avipox-based simian immunodeficiency virus (SIV) vaccines elicit a high frequency of SIV-specific CD4+ and CD8+ T-cell responses in vaccinia-experienced SIVmac251-infected macaques.

Nacsa J, Radaelli A, Edghill-Smith Y, Venzon D, Tsai WP, Morghen Cde G, Panicali D, Tartaglia J, Franchini G. Nacsa J, et al. Among authors: tartaglia j. Vaccine. 2004 Jan 26;22(5-6):597-606. doi: 10.1016/j.vaccine.2003.08.028. Vaccine. 2004. PMID: 14741150

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

193 results

Search Page